52% of innovations approved in 2020 have some limitation in their prescription or dispensing

HomeNews & Events

52% of innovations approved in 2020 have some limitation in their prescription or dispensing

El 52% de las innovaciones aprobadas en 2020 tienen alguna limitación a la prescripción o la dispensación

Omakase2021-02-10T12:16:21+00:00February 10th, 2021|News & Events|

Updated Annual Report on Orphan Drugs authorised in Spain and approved by the European Commission between 2003 & 2020

Updated Annual Report on Orphan Drugs authorised in Spain and approved by the European Commission between 2003 & 2020

April 9th, 2021 | 0 Comments
Alicia Gil, miembro de SWL

Alicia Gil, miembro de SWL

March 26th, 2021 | 0 Comments
The Omakase community grows to 1000 followers!

The Omakase community grows to 1000 followers!

March 16th, 2021 | 0 Comments
Dr Poveda and Dr Badia tell us how to use the Orphan Drugs Horizon Scanning report in Spain

Dr Poveda and Dr Badia tell us how to use the Orphan Drugs Horizon Scanning report in Spain

February 26th, 2021 | 0 Comments
We are proud to announce the release of Horizon Scanning 2020 where Omakase Consulting is working with Orphar-SEFH

We are proud to announce the release of Horizon Scanning 2020 where Omakase Consulting is working with Orphar-SEFH

February 23rd, 2021 | 0 Comments
CHMP positive opinions January 2021

CHMP positive opinions January 2021

February 2nd, 2021 | 0 Comments
Delighted to share an interesting debate, coordinated with Zogenix, about the Multiple Criteria Decision Analysis (MCDA) methodology as a new tool to empowerment of patients suffering from Dravet Syndrome.

Delighted to share an interesting debate, coordinated with Zogenix, about the Multiple Criteria Decision Analysis (MCDA) methodology as a new tool to empowerment of patients suffering from Dravet Syndrome.

December 23rd, 2020 | 0 Comments
It has been a pleasure to coordinate, together with Zogenix, a project directed to provide information, training and contribute to empowerment of patients suffering from Dravet Syndrome and their caregivers

It has been a pleasure to coordinate, together with Zogenix, a project directed to provide information, training and contribute to empowerment of patients suffering from Dravet Syndrome and their caregivers

December 21st, 2020 | 0 Comments

52% of innovations approved in 2020 have some limitation in their prescription or dispensing

52% of innovations approved in 2020 have some limitation in their prescription or dispensing

Share This Article

Related Posts

Leave A Comment Cancel reply